Single-Patient Case Report Links Advanced Colorectal Cancer to Later Lymphoma
A retrospective single-patient case report documents more than 10 years of survival after stage IV colorectal cancer followed by a ...
A retrospective single-patient case report documents more than 10 years of survival after stage IV colorectal cancer followed by a ...
A qualitative study of 22 Canadians receiving ongoing treatment for advanced cancer identified persistent symptoms, uncertainty, everyday disruption and difficulties ...
A prespecified interim analysis of the phase 3 HARMONi-2 trial shows ivonescimab achieved median overall survival of 30.8 months versus ...
New results from the global Phase I/II ARROS-1 trial indicate clinically meaningful activity with the investigational drug zidesamtinib in patients ...
A simulation study couples a chaotic three-dimensional tumor growth model with an advanced filtering technique to estimate tumor, host, and ...
Adenoid cystic carcinoma (ACC) is a rare malignancy of the salivary glands that typically follows an indolent yet persistent clinical ...
A single-center cohort study linked checkpoint inhibitor-containing therapy with longer unadjusted progression-free survival in advanced SMARCA4-deficient thoracic tumors, but adjusted ...
A meta-analysis of fourteen retrospective cohort studies associates TACE-HAIC combined with targeted therapy and immune checkpoint inhibitors with improved survival ...
Updated Phase 3 DUO-E trial results presented at ESMO 2026 show that durvalumab plus olaparib after chemotherapy achieved a median ...
Adding an immune checkpoint inhibitor to chemotherapy before surgery appears to dramatically improve how completely locally advanced cervical cancer responds ...
A subgroup analysis of the phase 3 RASolute 302 trial presented at ESMO found the targeted RAS inhibitor daraxonrasib extended ...
A phased handover of advanced HIV disease (AHD) services from external partners to Malawi's Ministry of Health was associated with ...
An outgoing editorial in the Journal of Cancer Survivorship: Research and Practice traces the field's evolution from descriptive studies to ...
The FDA granted accelerated approval for dostarlimab in adults with stage II or III locally advanced rectal cancer whose tumors ...
A review compares physical, chemical and hybrid crosslinking strategies for controlling the strength, recovery, injectability and degradation of Pluronic F127-based ...
An evidence review synthesized 30 studies into 24 statements for nursing physical activity management in advanced lung cancer.
A review of 972 patients found that histotripsy had low laboratory toxicity and procedural complication rates, while 11% died within ...
An exploratory BRIGHT-2 trial analysis associated longitudinal ctDNA patterns with prognosis, molecular response and candidate resistance alterations in advanced breast ...
A National Cancer Institute-funded phase 2/3 trial will test ivonescimab plus chemotherapy against standard chemoimmunotherapy in U.S. patients with advanced ...
A 2026 case report describes a 42-year-old man whose bleeding splenic lesions were diagnosed as primary splenic angiosarcoma after splenectomy, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.